Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Ischemia-Reperfusion Injury
NCT00441597Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Feb 2007; status: completed.
02
Drugs
atorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00441597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441597.